Endo International plc Securities Litigation (2020)

If you purchased a significant amount of shares of Endo International plc (NASDAQ: ENDP), you have certain options. Investors should register for updates.


Lawsuit Overview

Defendant:Endo International plc
Date Filed:June 19th, 2020
Sector:Health Care
Industry:Major Pharmaceuticals
Class Start Date:August 8th, 2017
Class End Date:June 9th, 2020

.According to the Complaint, Endo International plc manufactures and sells generic and branded pharmaceuticals in the U.S. and internationally, including both generic and branded opioid products. The Company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational, and compliance policies. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose: (i) the full scope of Endo's and/or its subsidiaries' contributions to the opioid crisis, including, but not limited to, their opioid products' disproportionately negative impact on New York, one of the most populous states in the U.S., as well as the fraud that Defendants perpetrated on the New York insurance market; (ii) part of that contribution to the crisis included Endo publishing and disseminating false information to health care providers regarding the risks and benefits of opioids; (iii) that the foregoing, once revealed, was foreseeably likely to subject Endo and/or its subsidiaries to increased regulatory scrutiny and enforcement, as well as significant financial and/or reputational harm, particularly with respect to New York; and (iv) that, as a result, the Company's public statements were materially false and misleading at all relevant times.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Endo International plc

First Identified Complaint

Benoit Albiges, et al. v. Endo International plc, et al.

Date Filed:June 19th, 2020
Class Period Start:August 8th, 2017
Class Period End:June 9th, 2020
First Identified Complaint Filings
#Document TitleFiling Date